img

Global SPECT and PET Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global SPECT and PET Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

SPECT and PET Radiopharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global SPECT and PET Radiopharmaceuticals market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for SPECT and PET Radiopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, SPECT and PET Radiopharmaceuticals key companies include GE Healthcare, Cardinal Health, Curium Pharma, China Isotope & Radiation, Jubilant Life Sciences, Bracco, Yantai Dongcheng Pharmaceutical, Lantheus Medical Imaging, Inc. and Eczacıbaşı Monrol Nuclear Products, etc. GE Healthcare, Cardinal Health, Curium Pharma are top 3 players and held % share in total in 2022.
SPECT and PET Radiopharmaceuticals can be divided into Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals and Positron Emission Tomography (PET) Radiopharmaceuticals, etc. Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals is the mainstream product in the market, accounting for % share globally in 2022.
SPECT and PET Radiopharmaceuticals is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the SPECT and PET Radiopharmaceuticals industry development. In 2022, global % share of SPECT and PET Radiopharmaceuticals went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global SPECT and PET Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


GE Healthcare
Cardinal Health
Curium Pharma
China Isotope & Radiation
Jubilant Life Sciences
Bracco
Yantai Dongcheng Pharmaceutical
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
Segment by Type
Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Positron Emission Tomography (PET) Radiopharmaceuticals

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the SPECT and PET Radiopharmaceuticals market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, SPECT and PET Radiopharmaceuticals introduction, etc. SPECT and PET Radiopharmaceuticals Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of SPECT and PET Radiopharmaceuticals market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of SPECT and PET Radiopharmaceuticals
1.1 SPECT and PET Radiopharmaceuticals Market Overview
1.1.1 SPECT and PET Radiopharmaceuticals Product Scope
1.1.2 SPECT and PET Radiopharmaceuticals Market Status and Outlook
1.2 Global SPECT and PET Radiopharmaceuticals Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2029)
1.4 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Region (2018-2024)
1.5 Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Region (2024-2029)
1.6 Key Regions, SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
1.6.1 North America SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
1.6.2 Europe SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
1.6.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
1.6.4 Latin America SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
1.6.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
2 SPECT and PET Radiopharmaceuticals Market by Type
2.1 Introduction
2.1.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2.1.2 Positron Emission Tomography (PET) Radiopharmaceuticals
2.2 Global SPECT and PET Radiopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Type (2018-2024)
2.2.2 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America SPECT and PET Radiopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.2 Europe SPECT and PET Radiopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America SPECT and PET Radiopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Breakdown by Type (2018-2029)
3 SPECT and PET Radiopharmaceuticals Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global SPECT and PET Radiopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Application (2018-2024)
3.2.2 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America SPECT and PET Radiopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.2 Europe SPECT and PET Radiopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America SPECT and PET Radiopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Breakdown by Application (2018-2029)
4 SPECT and PET Radiopharmaceuticals Competition Analysis by Players
4.1 Global SPECT and PET Radiopharmaceuticals Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in SPECT and PET Radiopharmaceuticals as of 2022)
4.3 Date of Key Players Enter into SPECT and PET Radiopharmaceuticals Market
4.4 Global Top Players SPECT and PET Radiopharmaceuticals Headquarters and Area Served
4.5 Key Players SPECT and PET Radiopharmaceuticals Product Solution and Service
4.6 Competitive Status
4.6.1 SPECT and PET Radiopharmaceuticals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.1.4 GE Healthcare SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.1.5 GE Healthcare Recent Developments
5.2 Cardinal Health
5.2.1 Cardinal Health Profile
5.2.2 Cardinal Health Main Business
5.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.2.4 Cardinal Health SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.2.5 Cardinal Health Recent Developments
5.3 Curium Pharma
5.3.1 Curium Pharma Profile
5.3.2 Curium Pharma Main Business
5.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.3.4 Curium Pharma SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.3.5 China Isotope & Radiation Recent Developments
5.4 China Isotope & Radiation
5.4.1 China Isotope & Radiation Profile
5.4.2 China Isotope & Radiation Main Business
5.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.4.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.4.5 China Isotope & Radiation Recent Developments
5.5 Jubilant Life Sciences
5.5.1 Jubilant Life Sciences Profile
5.5.2 Jubilant Life Sciences Main Business
5.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.5.4 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.5.5 Jubilant Life Sciences Recent Developments
5.6 Bracco
5.6.1 Bracco Profile
5.6.2 Bracco Main Business
5.6.3 Bracco SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.6.4 Bracco SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.6.5 Bracco Recent Developments
5.7 Yantai Dongcheng Pharmaceutical
5.7.1 Yantai Dongcheng Pharmaceutical Profile
5.7.2 Yantai Dongcheng Pharmaceutical Main Business
5.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.7.4 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.7.5 Yantai Dongcheng Pharmaceutical Recent Developments
5.8 Lantheus Medical Imaging, Inc.
5.8.1 Lantheus Medical Imaging, Inc. Profile
5.8.2 Lantheus Medical Imaging, Inc. Main Business
5.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.8.4 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.8.5 Lantheus Medical Imaging, Inc. Recent Developments
5.9 Eczacıbaşı Monrol Nuclear Products
5.9.1 Eczacıbaşı Monrol Nuclear Products Profile
5.9.2 Eczacıbaşı Monrol Nuclear Products Main Business
5.9.3 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.9.4 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.9.5 Eczacıbaşı Monrol Nuclear Products Recent Developments
5.10 Novartis International AG
5.10.1 Novartis International AG Profile
5.10.2 Novartis International AG Main Business
5.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.10.4 Novartis International AG SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.10.5 Novartis International AG Recent Developments
5.11 Siemens
5.11.1 Siemens Profile
5.11.2 Siemens Main Business
5.11.3 Siemens SPECT and PET Radiopharmaceuticals Products, Services and Solutions
5.11.4 Siemens SPECT and PET Radiopharmaceuticals Revenue (US$ Million) & (2018-2024)
5.11.5 Siemens Recent Developments
6 North America
6.1 North America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 SPECT and PET Radiopharmaceuticals Market Dynamics
11.1 SPECT and PET Radiopharmaceuticals Industry Trends
11.2 SPECT and PET Radiopharmaceuticals Market Drivers
11.3 SPECT and PET Radiopharmaceuticals Market Challenges
11.4 SPECT and PET Radiopharmaceuticals Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market SPECT and PET Radiopharmaceuticals Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global SPECT and PET Radiopharmaceuticals Market Size Share by Region (2018-2024)
Table 4. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size Share by Region (2024-2029)
Table 6. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2024)
Table 9. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 11. North America SPECT and PET Radiopharmaceuticals Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America SPECT and PET Radiopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe SPECT and PET Radiopharmaceuticals Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe SPECT and PET Radiopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America SPECT and PET Radiopharmaceuticals Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America SPECT and PET Radiopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2024)
Table 24. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 26. North America SPECT and PET Radiopharmaceuticals Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America SPECT and PET Radiopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe SPECT and PET Radiopharmaceuticals Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe SPECT and PET Radiopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America SPECT and PET Radiopharmaceuticals Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America SPECT and PET Radiopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Players (2018-2024)
Table 37. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in SPECT and PET Radiopharmaceuticals as of 2022)
Table 39. Date of Key Players Enter into SPECT and PET Radiopharmaceuticals Market
Table 40. Global SPECT and PET Radiopharmaceuticals Key Players Headquarters and Area Served
Table 41. SPECT and PET Radiopharmaceuticals Product Solution and Service
Table 42. Global SPECT and PET Radiopharmaceuticals Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GE Healthcare Basic Information List
Table 45. GE Healthcare Description and Business Overview
Table 46. GE Healthcare SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 47. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of GE Healthcare (2018-2024)
Table 48. GE Healthcare Recent Developments
Table 49. Cardinal Health Basic Information List
Table 50. Cardinal Health Description and Business Overview
Table 51. Cardinal Health SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 52. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Cardinal Health (2018-2024)
Table 53. Cardinal Health Recent Developments
Table 54. Curium Pharma Basic Information List
Table 55. Curium Pharma Description and Business Overview
Table 56. Curium Pharma SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 57. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Curium Pharma (2018-2024)
Table 58. Curium Pharma Recent Developments
Table 59. China Isotope & Radiation Basic Information List
Table 60. China Isotope & Radiation Description and Business Overview
Table 61. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 62. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of China Isotope & Radiation (2018-2024)
Table 63. China Isotope & Radiation Recent Developments
Table 64. Jubilant Life Sciences Basic Information List
Table 65. Jubilant Life Sciences Description and Business Overview
Table 66. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 67. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Jubilant Life Sciences (2018-2024)
Table 68. Jubilant Life Sciences Recent Developments
Table 69. Bracco Basic Information List
Table 70. Bracco Description and Business Overview
Table 71. Bracco SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 72. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Bracco (2018-2024)
Table 73. Bracco Recent Developments
Table 74. Yantai Dongcheng Pharmaceutical Basic Information List
Table 75. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 76. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 77. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Yantai Dongcheng Pharmaceutical (2018-2024)
Table 78. Yantai Dongcheng Pharmaceutical Recent Developments
Table 79. Lantheus Medical Imaging, Inc. Basic Information List
Table 80. Lantheus Medical Imaging, Inc. Description and Business Overview
Table 81. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 82. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Lantheus Medical Imaging, Inc. (2018-2024)
Table 83. Lantheus Medical Imaging, Inc. Recent Developments
Table 84. Eczacıbaşı Monrol Nuclear Products Basic Information List
Table 85. Eczacıbaşı Monrol Nuclear Products Description and Business Overview
Table 86. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 87. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Eczacıbaşı Monrol Nuclear Products (2018-2024)
Table 88. Eczacıbaşı Monrol Nuclear Products Recent Developments
Table 89. Novartis International AG Basic Information List
Table 90. Novartis International AG Description and Business Overview
Table 91. Novartis International AG SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 92. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Novartis International AG (2018-2024)
Table 93. Novartis International AG Recent Developments
Table 94. Siemens Basic Information List
Table 95. Siemens Description and Business Overview
Table 96. Siemens SPECT and PET Radiopharmaceuticals Products, Services and Solutions
Table 97. Revenue (US$ Million) in SPECT and PET Radiopharmaceuticals Business of Siemens (2018-2024)
Table 98. Siemens Recent Developments
Table 99. North America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Region (2018-2024)
Table 107. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Region (2024-2029)
Table 108. Latin America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 114. SPECT and PET Radiopharmaceuticals Market Trends
Table 115. SPECT and PET Radiopharmaceuticals Market Drivers
Table 116. SPECT and PET Radiopharmaceuticals Market Challenges
Table 117. SPECT and PET Radiopharmaceuticals Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global SPECT and PET Radiopharmaceuticals Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global SPECT and PET Radiopharmaceuticals Market Share by Regions: 2022 VS 2029
Figure 4. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe SPECT and PET Radiopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Figure 11. Global Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Positron Emission Tomography (PET) Radiopharmaceuticals
Figure 13. Global Positron Emission Tomography (PET) Radiopharmaceuticals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global SPECT and PET Radiopharmaceuticals Market Size Share by Type: 2022 & 2029
Figure 15. North America SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2029)
Figure 16. Europe SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2029)
Figure 18. Latin America SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2029)
Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global SPECT and PET Radiopharmaceuticals Market Size Share by Application: 2022 & 2029
Figure 24. North America SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2029)
Figure 25. Europe SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2029)
Figure 27. Latin America SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2029)
Figure 29. SPECT and PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players SPECT and PET Radiopharmaceuticals Market Share in 2022
Figure 31. North America SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 32. United States SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 33. Canada SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 34. Germany SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 35. France SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 37. Italy SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 38. Russia SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Region (2018-2029)
Figure 41. China SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 42. Japan SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 45. India SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 46. Australia SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 48. Mexico SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 51. Turkey SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 53. UAE SPECT and PET Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report